CSX Corp. CSX is one of the big American railroads. It reported strong earnings for the first quarter which beat the Zacks Consensus Estimate by 11 cents. Analysts are bullish and raising estimates for the full year. Earnings are expected to grow in the double digits this year and next. CSX is trading more like a technology stock than an old railroad. Shares are up 26% year-to-date and have a 20-year return of over 1500%. CSX is a Zacks Rank #2 (Buy).
BioTelemetry BEAT is a healthcare innovator in the remote medical technology category, especially in the heart area. It has teamed up with Apple in collecting heart data. Shares are down 7% year-to-date and now trade with a forward P/E of just 28. The company reports earnings on Apr 25. It’s a Zacks Rank #1 (Strong Buy).
Should these three companies be on your investing short list? Find out in this week’s video.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CSX Corporation (CSX) : Free Stock Analysis Report
BioTelemetry, Inc. (BEAT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research